Clinical Trial Update: Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for VLA15 vaccine against Lyme borreliosis; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Borreliosis

Drugs mentioned

• VLA15

Snippet

Sponsor: Pfizer | Conditions: Lyme Borreliosis | Phase 2 | Status: COMPLETED | Results posted: 2021-07-08